Vaccines against Toxoplasma gondii: status, challenges and future directions.
about
Fatal Toxoplasma gondii infection in the giant pandaDiagnosis of toxoplasmosis and typing of Toxoplasma gondiiProtective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticlesParasite Carbohydrate Vaccines.Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in miceToxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity.Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice.Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c miceInduction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1.Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Recent advances in Toxoplasma gondii immunotherapeutics.Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.Reducing zoonotic and internal parasite burdens in pigs using a pig confinement system.Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients.Moving towards improved vaccines for Toxoplasma gondii.
P2860
Q22809979-ADC1ED2B-1C5C-4DAF-A90A-EFEE7E0EBDB7Q26998428-8FA5115E-D0A3-4970-91F6-251B4CC08392Q28846409-418FDD98-B46D-483D-B60E-F6F000DAACE2Q33785863-63852509-219F-4A1A-B9BD-B52E320C86A0Q34257517-F46446A0-8DCF-4B65-BDF7-5851AAAEE0A6Q34271620-0126BE7C-08EA-4BE8-A3A9-F88812E9C994Q34709118-37D50F8D-E47F-4210-9A7F-D6DCF06A76E2Q35609307-02A17782-B4C4-446A-8BDB-81EBBAA0563FQ36156444-85A16628-E343-41DC-8C04-FF4CD7CB7B7DQ36246596-F026E7D3-E605-4B41-AEFE-D75E47037838Q36943560-C30ED7AB-37B6-4CC7-AD33-DAAD24E8E598Q37737615-0E53179C-8065-4E92-96CF-9EC23C7C6853Q38303517-6BBA2A3A-9693-4358-9069-0C8D38867003Q39287046-E9D17BC7-A439-49DC-AB91-D40A9829F123Q47108773-AF4B2E5F-6077-4FA3-9348-A3E10BE8D751Q47133999-D4C720B1-6D73-4EF5-8FFA-70C22C37F08CQ47318857-49485C42-7251-4D04-846A-1CA030DCFB55
P2860
Vaccines against Toxoplasma gondii: status, challenges and future directions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@ast
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@en
type
label
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@ast
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@en
prefLabel
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@ast
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@en
P2093
P2860
P356
P1476
Vaccines against Toxoplasma gondii: status, challenges and future directions.
@en
P2093
Huaiyu Zhou
Lachhman Das Singla
P2860
P304
P356
10.4161/HV.21006
P577
2012-08-21T00:00:00Z